These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 696210)

  • 1. Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.
    Patrone F; Dallegri F; Sacchetti C
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):322-3. PubMed ID: 696210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
    Hermanowicz A; Sliwiński Z; Kaczor R
    Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute polyarthropathy associated with levamisole therapy in a patient with Crohn's disease.
    Benfield GF; Felix-Davies DD; Thompson RA; Asquith P
    Eur J Rheumatol Inflamm; 1984; 7(2):63-5. PubMed ID: 6571261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Letter: Crohn's disease and levamisole].
    Bertrand J; Renoux G; Renoux M; Palat A
    Nouv Presse Med; 1974 Oct; 3(35):2265. PubMed ID: 4617861
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
    Brandt E; Müller-Alouf H; Desreumaux P; Woerly G; Colombel JF; Capron M
    Eur Cytokine Netw; 1998 Dec; 9(4):647-53. PubMed ID: 9889409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.
    Anderson R; Glover A; Koornhof HJ; Rabson AR
    J Immunol; 1976 Aug; 117(2):428-32. PubMed ID: 181491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crohn's disease of the colon treated with high doses of levamisole].
    Tixier P; Verger JB; Rabia M; Bardeche P; Brodi L
    Nouv Presse Med; 1978 Dec; 7(43):3942. PubMed ID: 733561
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side effect of levamisole during Crohn's disease].
    Dupas JL; Capron JP; Delamarre J; Lorriaux A
    Nouv Presse Med; 1979 Apr; 8(16):1350-1. PubMed ID: 482107
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.
    D'Amelio R; Rossi P; Le Moli S; Ricci R; Montano S; Pallone F
    Gut; 1981 Jul; 22(7):566-70. PubMed ID: 7262631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole induced granulocytopenia and thrombocytopenia in a case of Crohn's colitis.
    Sategna-Guidetti C; Peyre S
    Gastroenterol Clin Biol; 1979 Jan; 3(1):104. PubMed ID: 437394
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of nitroimidazole derivatives on leukocyte migration.
    Gnarpe H; Belsheim J; Persson S
    Scand J Infect Dis Suppl; 1981; 26():68-71. PubMed ID: 6941458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole in Crohn's disease--a double-blind controlled trial.
    Wesdorp E; Schellekens PT; Weening RS; Meuwissen SG; Tytgat GN
    Digestion; 1978; 18(3-4):186-91. PubMed ID: 367851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil dysfunction in Crohn's disease.
    Segal AW; Loewi G
    Lancet; 1976 Jul; 2(7979):219-21. PubMed ID: 59239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between Crohn's disease, periodontal disease and enhanced neutrophil function.
    Lamster I; Sonis S; Hannigan A; Kolodkin A
    J Periodontol; 1978 Sep; 49(9):475-9. PubMed ID: 364004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary effects of levamisole in Crohn's disease].
    Villand J; Carli H
    Nouv Presse Med; 1979 Nov; 8(45):3753. PubMed ID: 534237
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukotriene B4 receptor levels and intracellular calcium signalling in polymorphonuclear leukocytes from patients with Crohn's disease.
    Bouchelouche PN; Berild D; Nielsen OH; Elmgreen J; Poulsen HS
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):349-56. PubMed ID: 7600141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.